Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Salivary calcium ions refer to the cytosolic calcium ions ([Ca²⁺]ᵢ) in salivary gland acinar cells, which serve as a critical second messenger regulating fluid secretion and ion transport. Stimulation by neurotransmitters triggers inositol 1,4,5-trisphosphate (IP₃)-mediated release of Ca²⁺ from endoplasmic reticulum stores via IP₃ receptors (primarily IP₃R2 and IP₃R3), initiating a localized apical-to-basolateral Ca²⁺ wave that activates Ca²⁺-dependent K⁺, Cl⁻ channels, and transporters like Na⁺-K⁺-2Cl⁻ cotransporter to drive transepithelial Cl⁻ flux and osmotic water movement through aquaporin-5. Sustained [Ca²⁺]ᵢ elevation requires store-operated Ca²⁺ entry (SOCE) via plasma membrane channels including Orai1, TRPC1, TRPC3, gated by ER sensors STIM1 and STIM2, ensuring prolonged secretion. Dysregulated Ca²⁺ signaling, such as excessive SOCE or ROS-activated TRPM2 channels, contributes to salivary gland dysfunction, cell damage, ER stress, and conditions like xerostomia, but calcium ions themselves are not pursued as direct therapeutic targets; instead, modulators like IP₃R or SOCE components are studied.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salivary calcium ions.